TALIS BIOMEDICAL CORP (TLIS) Stock Overview
USA - NASDAQ:TLIS - US87424L2079 - Common Stock
TLIS Key Statistics, Chart & Performance
The current stock price of TLIS is 4.38 USD. In the past month the price decreased by -50.79%. In the past year, price decreased by -27.24%.
TLIS Latest News, Press Relases and Analysis
TLIS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.15 | 231.52B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.78 | 158.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.89 | 142.10B | ||
| SYK | STRYKER CORP | 28.73 | 141.16B | ||
| MDT | MEDTRONIC PLC | 17.78 | 126.13B | ||
| BDX | BECTON DICKINSON AND CO | 13.49 | 55.18B | ||
| IDXX | IDEXX LABORATORIES INC | 52.23 | 50.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.85 | 45.04B | ||
| RMD | RESMED INC | 29.66 | 41.48B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.98 | 34.01B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.57 | 26.80B | ||
| DXCM | DEXCOM INC | 38.84 | 25.89B |
Related stock screener links
About TLIS
Company Profile
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
Company Info
TALIS BIOMEDICAL CORP
1375 West Fulton Market, Suite 700
Chicago ILLINOIS 94025 US
CEO: Brian Coe
Employees: 99
Phone: 16504333000
TALIS BIOMEDICAL CORP / TLIS FAQ
What is the stock price of TALIS BIOMEDICAL CORP today?
The current stock price of TLIS is 4.38 USD. The price increased by 5.29% in the last trading session.
What is the ticker symbol for TALIS BIOMEDICAL CORP stock?
The exchange symbol of TALIS BIOMEDICAL CORP is TLIS and it is listed on the Nasdaq exchange.
On which exchange is TLIS stock listed?
TLIS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TALIS BIOMEDICAL CORP stock?
6 analysts have analysed TLIS and the average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38. Check the TALIS BIOMEDICAL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TALIS BIOMEDICAL CORP worth?
TALIS BIOMEDICAL CORP (TLIS) has a market capitalization of 7.97M USD. This makes TLIS a Nano Cap stock.
How many employees does TALIS BIOMEDICAL CORP have?
TALIS BIOMEDICAL CORP (TLIS) currently has 99 employees.
What are the support and resistance levels for TALIS BIOMEDICAL CORP (TLIS) stock?
TALIS BIOMEDICAL CORP (TLIS) has a resistance level at 4.52. Check the full technical report for a detailed analysis of TLIS support and resistance levels.
Is TALIS BIOMEDICAL CORP (TLIS) expected to grow?
The Revenue of TALIS BIOMEDICAL CORP (TLIS) is expected to decline by -100% in the next year. Check the estimates tab for more information on the TLIS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TALIS BIOMEDICAL CORP (TLIS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TLIS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TLIS, evaluating the profitability, health, valuation and growth aspects
- TALIS BIOMEDICAL CORP (TLIS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TALIS BIOMEDICAL CORP (TLIS) Sales and EPS estimates to see what analysts future expectations are.
- TALIS BIOMEDICAL CORP (TLIS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TALIS BIOMEDICAL CORP (TLIS) Insider and Institutional Ownership to learn about the owners and their transactions.
- TALIS BIOMEDICAL CORP (TLIS) Stock Chart to make your own analysis
- TALIS BIOMEDICAL CORP (TLIS) Latest news and press-releases to stay up to date.
Does TALIS BIOMEDICAL CORP (TLIS) stock pay dividends?
TLIS does not pay a dividend.
When does TALIS BIOMEDICAL CORP (TLIS) report earnings?
TALIS BIOMEDICAL CORP (TLIS) will report earnings on 2024-11-12, after the market close.
What is the Price/Earnings (PE) ratio of TALIS BIOMEDICAL CORP (TLIS)?
TALIS BIOMEDICAL CORP (TLIS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-31.43).
What is the Short Interest ratio of TALIS BIOMEDICAL CORP (TLIS) stock?
The outstanding short interest for TALIS BIOMEDICAL CORP (TLIS) is 0.32% of its float. Check the ownership tab for more information on the TLIS short interest.
TLIS Technical Analysis
TLIS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLIS. TLIS has a great financial health rating, but its profitability evaluates not so good.
TLIS Financial Highlights
Over the last trailing twelve months TLIS reported a non-GAAP Earnings per Share(EPS) of -31.43. The EPS increased by 42.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.35% | ||
| ROE | -100.93% | ||
| Debt/Equity | 0 |
TLIS Forecast & Estimates
6 analysts have analysed TLIS and the average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38.
For the next year, analysts expect an EPS growth of 27.62% and a revenue growth -100% for TLIS